Clinical trial
A Research Study to See if a Change in Therapy for HIV Infection Can Improve the…
NCT00145795 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00145795 |
|---|---|
| Title | A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment |
| Official title | Randomized Trial of a Switch to a Kaletra + Current Dual Nucleoside Reverse Transcriptase Inhibitor (NRTI) Backbone Versus Continuation of the Current Regimen in Patients With Poor Immune Responses to Highly Active Antiretroviral Therapy (HAART) in Patients With Complete Viral Suppression: A Pilot… |
| Lead sponsor | University of Chicago, Other |
| Collaborators | Abbott Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Kaletra + Current Dual NRTI Backbone, Current Regimen |
| Enrollment | 20 |
| Start date | Apr 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 5, 2005 |
| Last update posted | Jun 15, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: